Primary Radiation Therapy in Patients With Localized Orbital Marginal Zone B-Cell Lymphoma of Mucosa-Associated Lymphoid Tissue (MALT Lymphoma)

International Journal of Radiation Oncology Biology Physics

Volumn 77, Issue 1, 2010, Pages 86-91

  Son, Seok Hyun ^a   Choi, Byung Ock ^a   Kim, Gi Won ^a   Yang, Suk Woo ^a   Hong, Young Seon ^a   Choi, Ihl Bohng ^b   Kim, Yeon Sil ^a  

^a The Catholic University of Korea   (South Korea)

^b Gimpo Airport Wooridul Spine Hospital   (South Korea)

Author keywords

Marginal zone B cell lymphoma of mucosa associated lymphoid tissue (MALT); Orbit; Radiotherapy (RT)

Indexed keywords

B-CELL LYMPHOMA; CAUSE-SPECIFIC SURVIVAL; LOCALIZED ORBITALS; MARGINAL ZONE; MUCOSA-ASSOCIATED LYMPHOID TISSUE; OVERALL SURVIVAL; PARTIAL REMISSION; PRIMARY RADIATIONS; RADIATION DOSE; REIRRADIATION; TREATMENT MODALITY;

CHEMOTHERAPY; ENZYMES; RADIOTHERAPY;

ONCOLOGY;

ARTIFICIAL TEAR; CYCLOPHOSPHAMIDE; DOXORUBICIN; EYE DROPS; PREDNISONE; VINCRISTINE;

ADULT; AGED; ARTICLE; CANCER CHEMOTHERAPY; CANCER LOCALIZATION; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER REGRESSION; CANCER RELAPSE; CANCER STAGING; CANCER SURVIVAL; CLINICAL ARTICLE; CONJUNCTIVITIS; CORNEA PERFORATION; CORNEA ULCER; DRY EYE; EPIPHORA; FEMALE; FOLLOW UP; GLAUCOMA; HUMAN; KERATITIS; LACRIMAL DUCT OCCLUSION; MALE; MARGINAL ZONE LYMPHOMA; MEDICAL RECORD REVIEW; MUCOSA ASSOCIATED LYMPHOID TISSUE LYMPHOMA; OPHTHALMOPLEGIA; OPTIC NERVE LESION; ORBITAL LYMPHOMA; OUTCOME ASSESSMENT; OVERALL SURVIVAL; PERIORBITAL EDEMA; PRIORITY JOURNAL; RADIATION CATARACT; RADIATION DOSE; REPEAT PROCEDURE; RETINOPATHY; RETROSPECTIVE STUDY; SALVAGE THERAPY; TREATMENT DURATION;

ADULT; AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CATARACT; CONJUNCTIVAL NEOPLASMS; CYCLOPHOSPHAMIDE; DOXORUBICIN; EYELID NEOPLASMS; FEMALE; HUMANS; LACRIMAL DUCT OBSTRUCTION; LYMPHOMA, B-CELL, MARGINAL ZONE; MALE; MIDDLE AGED; ORBITAL NEOPLASMS; PREDNISONE; RADIATION INJURIES; RADIOTHERAPY DOSAGE; REMISSION INDUCTION; RETREATMENT; RETROSPECTIVE STUDIES; SALVAGE THERAPY; TREATMENT OUTCOME; VINCRISTINE; YOUNG ADULT;

EID: 77950561663     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijrobp.2009.04.018     Document Type: Article

References (18)

1. Isaacson P., and Wright D.H. Malignant lymphoma of mucosa-associated lymphoid tissue. A distinctive type of B-cell lymphoma. Cancer 52 (1983) 1410-1416
2. Suh C.O., Shim S.J., Lee S.W., et al. Orbital marginal zone B-cell lymphoma of MALT: Radiotherapy results and clinical behavior. Int J Radiat Oncol Biol Phys 65 (2006) 228-233
3. Lee J.L., Kim M.K., Lee K.H., et al. Extranodal marginal zone B-cell lymphomas of mucosa-associated lymphoid tissue-type of the orbit and ocular adnexa. Ann Hematol 84 (2005) 13-18
4. Uno T., Isobe K., Shikama N., et al. Radiotherapy for extranodal, marginal zone, B-cell lymphoma of mucosa-associated lymphoid tissue originating in the ocular adnexa: A multiinstitutional, retrospective review of 50 patients. Cancer 98 (2003) 865-871
5. Le Q.T., Eulau S.M., George T.I., et al. Primary radiotherapy for localized orbital MALT lymphoma. Int J Radiat Oncol Biol Phys 52 (2002) 657-663
6. Ejima Y., Sasaki R., Okamoto Y., et al. Ocular adnexal mucosa-associated lymphoid tissue lymphoma treated with radiotherapy. Radiother Oncol 78 (2006) 6-9
7. Tsang R.W., Gospodarowicz M.K., Pintilie M., et al. Localized mucosa-associated lymphoid tissue lymphoma treated with radiation therapy has excellent clinical outcome. J Clin Oncol 21 (2003) 4157-4164
8. Ko Y.H., Kim C.W., Park C.S., et al. REAL classification of malignant lymphomas in the Republic of Korea: Incidence of recently recognized entities and changes in clinicopathologic features. Hematolymphoreticular Study Group of the Korean Society of Pathologists. Revised European-American lymphoma. Cancer 83 (1998) 806-812
9. Suzuki J., Ohguro H., Oguri N., et al. Clinicopathologic and immunogenetic analysis of mucosa-associated lymphoid tissue lymphomas arising in conjunctiva. Jpn J Ophthalmol 43 (1999) 155-161
10. Fung C.Y., Tarbell N.J., Lucarelli M.J., et al. Ocular adnexal lymphoma: Clinical behavior of distinct World Health Organization classification subtypes. Int J Radiat Oncol Biol Phys 57 (2003) 1382-1391
11. Zhou P., Ng A.K., Silver B., et al. Radiation therapy for orbital lymphoma. Int J Radiat Oncol Biol Phys 63 (2005) 866-871
12. Wenzel C., Fiebiger W., Dieckmann K., et al. Extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue of the head and neck area: High rate of disease recurrence following local therapy. Cancer 97 (2003) 2236-2241
13. Pfeffer M.R., Rabin T., Tsvang L., et al. Orbital lymphoma: Is it necessary to treat the entire orbit?. Int J Radiat Oncol Biol Phys 60 (2004) 527-530
14. Hitchcock S., Ng A.K., Fisher D.C., et al. Treatment outcome of mucosa-associated lymphoid tissue/marginal zone non-Hodgkin's lymphoma. Int J Radiat Oncol Biol Phys 52 (2002) 1058-1066
15. Deeg H.J., Flournoy N., Sullivan K.M., et al. Cataracts after total body irradiation and marrow transplantation: A sparing effect of dose fractionation. Int J Radiat Oncol Biol Phys 10 (1984) 957-964
16. Merriam G.R., and Focht E.F. A clinical study of radiation cataracts and the relationship to dose. AJR Am J Roentgenol 77 (1957) 759-785
17. Henk J.M., Whitelocke R.A., Warrington A.P., et al. Radiation dose to the lens and cataract formation. Int J Radiat Oncol Biol Phys 25 (1993) 815-820
18. Takeda A., Shigematsu N., Suzuki S., et al. Late retinal complications of radiation therapy for nasal and paranasal malignancies: Relationship between irradiated-dose area and severity. Int J Radiat Oncol Biol Phys 44 (1999) 599-605